Back to Menu
1. Curative surgical treatment
The primary curative approach for early-stage disease. Surgical strategy is selected according to tumor location, aiming for negative margins with lymph node dissection.
2. Minimally invasive surgery
Laparoscopic and robot-assisted approaches reduce surgical trauma and accelerate recovery, and may be suitable for selected intrahepatic cases and early perihilar disease.
3. Liver transplantation
May be considered for strictly selected patients with intrahepatic cholangiocarcinoma; disease control with bridging therapy is required before transplantation.
4. Chemotherapy
Gemcitabine plus cisplatin is a first-line regimen and can be used in neoadjuvant, adjuvant, or palliative settings depending on stage and resectability.
5. Radiotherapy
Includes external beam radiotherapy and intraluminal brachytherapy; precision techniques enable dose escalation while protecting normal tissues.
6. Targeted therapy
Agents targeting FGFR2 alterations or IDH1 mutations require genomic testing to select eligible patients, enabling individualized precision therapy.
7. Immunotherapy
PD-1/PD-L1 inhibitors have shown efficacy in selected patients and are often used in combination with other modalities.
8. Interventional therapy
Includes transarterial chemoembolization (TACE) and ablation, applicable to unresectable intrahepatic cholangiocarcinoma.
9. Photodynamic therapy
After administration of a photosensitizer, laser activation selectively damages tumor tissue and can palliate biliary obstruction.
10. Symptomatic and supportive care
Biliary drainage, nutritional support, and pain control improve quality of life and create conditions for further therapy.
11. Integrative traditional Chinese and Western medicine
Traditional Chinese medicine may be used as an adjunct therapy under professional guidance to mitigate the toxic effects of chemoradiotherapy and to improve clinical symptoms.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that cholangiocarcinoma is therapeutically complex and often carries a poor prognosis, posing a serious threat to life. Early diagnosis and standardized treatment can substantially improve outcomes, increase the opportunity for surgery, and enhance quality of life. Multidisciplinary team (MDT)–based collaboration and individualized treatment planning are essential for improving therapeutic outcomes. Patients are encouraged to maintain confidence and to actively participate in their treatment and care.
1. Curative surgical treatment
The primary curative approach for early-stage disease. Surgical strategy is selected according to tumor location, aiming for negative margins with lymph node dissection.
2. Minimally invasive surgery
Laparoscopic and robot-assisted approaches reduce surgical trauma and accelerate recovery, and may be suitable for selected intrahepatic cases and early perihilar disease.
3. Liver transplantation
May be considered for strictly selected patients with intrahepatic cholangiocarcinoma; disease control with bridging therapy is required before transplantation.
4. Chemotherapy
Gemcitabine plus cisplatin is a first-line regimen and can be used in neoadjuvant, adjuvant, or palliative settings depending on stage and resectability.
5. Radiotherapy
Includes external beam radiotherapy and intraluminal brachytherapy; precision techniques enable dose escalation while protecting normal tissues.
6. Targeted therapy
Agents targeting FGFR2 alterations or IDH1 mutations require genomic testing to select eligible patients, enabling individualized precision therapy.
7. Immunotherapy
PD-1/PD-L1 inhibitors have shown efficacy in selected patients and are often used in combination with other modalities.
8. Interventional therapy
Includes transarterial chemoembolization (TACE) and ablation, applicable to unresectable intrahepatic cholangiocarcinoma.
9. Photodynamic therapy
After administration of a photosensitizer, laser activation selectively damages tumor tissue and can palliate biliary obstruction.
10. Symptomatic and supportive care
Biliary drainage, nutritional support, and pain control improve quality of life and create conditions for further therapy.
11. Integrative traditional Chinese and Western medicine
Traditional Chinese medicine may be used as an adjunct therapy under professional guidance to mitigate the toxic effects of chemoradiotherapy and to improve clinical symptoms.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that cholangiocarcinoma is therapeutically complex and often carries a poor prognosis, posing a serious threat to life. Early diagnosis and standardized treatment can substantially improve outcomes, increase the opportunity for surgery, and enhance quality of life. Multidisciplinary team (MDT)–based collaboration and individualized treatment planning are essential for improving therapeutic outcomes. Patients are encouraged to maintain confidence and to actively participate in their treatment and care.